Medication info

Rivatoro Tablets 4 mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›4.409mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Light yellow round film-coated tablet
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202103408 · Approved 2021.04.27

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response. The therapeutic effect of this medication is maintained with continued treatment.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apolipoprotein B
  • elevated triglycerides
View approved original text

This medication helps lower high total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing good cholesterol levels (HDL cholesterol). It is used to reduce the risk of cardiovascular disease by improving blood lipid levels when used in combination with diet therapy.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response. The therapeutic effect of this medication is maintained with continued treatment.

Precautions

This medication should not be used in patients who are allergic to certain ingredients. Patients with poor liver function or liver disease should also not take this medication. Patients with renal dysfunction or myopathy should avoid this medication. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not use this medication. The safety and efficacy of this medication have not been established in children, so it is not used in this population. Patients with lactose intolerance or certain genetic disorders should not take this medication. Patients allergic to soybean oil, soy, or peanuts should also exercise caution. Patients with impaired renal function or liver dysfunction should use this medication with caution, especially if taking other specific drugs, as there is an increased risk of muscle damage and renal function deterioration. Elderly individuals or patients with hypothyroidism, diabetes, or lipid metabolism disorders should exercise special caution when taking this medication. While taking this medication, symptoms such as muscle pain, weakness, abdominal pain, rash, and itching may occur, and liver function abnormalities or changes in blood test results may occur, so regular testing is necessary. Particularly, if muscle-related abnormal symptoms appear, the medication should be stopped immediately, and a doctor should be consulted. This medication can interact with other specific drugs, such as with cyclosporine or fibrate medications and niacin, which may increase the risk of renal function deterioration and muscle damage; therefore, concurrent use should be avoided or used with great caution. Before taking this medication, lifestyle modifications such as diet and exercise should be considered first, and if no effect is seen, the medication should be discontinued. Patients with poor liver function should start with a low dose and undergo regular liver function tests and blood lipid tests during treatment. Pregnant or breastfeeding women should not take this medication, and women planning to conceive should consult a doctor before taking it. The tablets should be swallowed whole without dividing, and stored out of reach of children. This medication may cause adverse reactions more frequently in the elderly, so special caution is required during use. Additionally, rare but serious conditions such as severe muscle weakness, interstitial lung disease, and worsening diabetes have been reported, so if these symptoms are suspected, immediate consultation with healthcare professionals is necessary.

Side effects

  • Abdominal pain
  • rash
  • lethargy
  • paralysis
  • itching
  • muscle pain
  • weakness
  • increased CPK levels
  • elevated myoglobin in blood and urine
  • acute renal failure
Show 77 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • hives
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • rigidity
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • discomfort in the stomach
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • increased BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • loss of strength
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste disturbances
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • facial edema
  • arm swelling
  • hypersensitivity
  • headache
  • skin tingling
  • insomnia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light to enter. It is also best to keep the medication at room temperature between 1°C and 30°C. This will help maintain the effectiveness of the medication for a longer time.

Appearance and packaging

Appearance

Light yellow round film-coated tablet

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.